Bob Repella

Mimecast Microsoft Office 365 Outlook Amazon AWS Netlify React Salesforce Adobe Marketing Cloud Mobile Friendly Vimeo Wix Google Tag Manager YouTube Google Analytics Varnish Android Render IoT Remote AI

biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing sleep disorders neurobehavioral disorders rare diseases fda approval clinical trials patient-focused drug development novel treatments narcolepsy hypersomnia cataplexy drug development pipeline brain health neurology fragile x syndrome prader-willi syndrome myotonic dystrophy epilepsy treatment dravet syndrome lennox-gastaut syndrome developmental encephalopathy patient advocacy community support strategic partnerships pharmaceutical research clinical research behavioral health excessive daytime sleepiness innovative therapeutics drug formulation hormonal balance patient insights healthcare solutions biopharmaceuticals safety data reports medical affairs neurological diseases orphan drug designation drug commercialization scientific innovation patient engagement community impact therapeutic innovations clinical efficacy compliance standards collaborative care patient resources rare neurological disorders innovative therapies patient-centric innovation sleep/wake disorders fda-approved treatments wakix therapeutic development unmet medical needs community engagement healthcare providers digital marketing pharmaceutical industry neurobehavioral conditions pipeline products empathy collaboration healthcare compliance regulatory agencies specialized market healthcare professionals quality of life therapeutic innovation pediatric patients next-generation formulations community resources education for patients advocacy support investigator sponsored studies neuroscience research health wellness & fitness pharmaceuticals medical hospital & health care marketing & advertising